Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies

Cancers - Switzerland
doi 10.3390/cancers11091382
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG